1. Home
  2. ACXP vs AMBO Comparison

ACXP vs AMBO Comparison

Compare ACXP & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • AMBO
  • Stock Information
  • Founded
  • ACXP 2017
  • AMBO 2000
  • Country
  • ACXP United States
  • AMBO United States
  • Employees
  • ACXP N/A
  • AMBO N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • AMBO Other Consumer Services
  • Sector
  • ACXP Health Care
  • AMBO Real Estate
  • Exchange
  • ACXP Nasdaq
  • AMBO Nasdaq
  • Market Cap
  • ACXP 8.4M
  • AMBO 7.0M
  • IPO Year
  • ACXP 2021
  • AMBO 2010
  • Fundamental
  • Price
  • ACXP $0.47
  • AMBO $2.95
  • Analyst Decision
  • ACXP Strong Buy
  • AMBO
  • Analyst Count
  • ACXP 2
  • AMBO 0
  • Target Price
  • ACXP $10.00
  • AMBO N/A
  • AVG Volume (30 Days)
  • ACXP 18.7M
  • AMBO 11.7K
  • Earning Date
  • ACXP 08-08-2025
  • AMBO 01-01-0001
  • Dividend Yield
  • ACXP N/A
  • AMBO N/A
  • EPS Growth
  • ACXP N/A
  • AMBO N/A
  • EPS
  • ACXP N/A
  • AMBO 0.11
  • Revenue
  • ACXP N/A
  • AMBO $9,392,000.00
  • Revenue This Year
  • ACXP N/A
  • AMBO N/A
  • Revenue Next Year
  • ACXP N/A
  • AMBO N/A
  • P/E Ratio
  • ACXP N/A
  • AMBO $27.31
  • Revenue Growth
  • ACXP N/A
  • AMBO 2.50
  • 52 Week Low
  • ACXP $0.30
  • AMBO $1.00
  • 52 Week High
  • ACXP $3.33
  • AMBO $5.55
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 52.38
  • AMBO 60.08
  • Support Level
  • ACXP $0.45
  • AMBO $2.25
  • Resistance Level
  • ACXP $0.59
  • AMBO $2.70
  • Average True Range (ATR)
  • ACXP 0.08
  • AMBO 0.29
  • MACD
  • ACXP -0.01
  • AMBO 0.08
  • Stochastic Oscillator
  • ACXP 27.06
  • AMBO 72.97

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

Share on Social Networks: